Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
For all trial sponsors, the current clinical development landscape is increasingly complex, creating multipronged challenges to successful drug or device development. However, roadblocks that hinder development vary from sponsor to sponsor. To successfully design and execute your trial portfolio, it is important to examine the specific hurdles that impact efficiency such as gaps in technology, expertise, processes or data solutions. In doing so, working with IQVIA's FSP to identify areas of concern and tackle them head on by developing a tailored FSP model, integrating the right mix of components to optimize development. As effective trial management and patient recruitment can go hand-in-hand, IQVIA created the FSP Advance Trial Management and Direct-to-Patient Recruitment model to co-design tailored solutions leveraging a selection of synergistic components to heighten efficiency in these critical areas. This individually customized FSP model is designed to integrate functional solutions across IQVIA to meet you where you are in your journey, addressing evolving needs with flexibility and achieving your objectives in trial speed, quality and/or costs.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.